WinstonWınston
Back
Claritev Corporation logo

Claritev Corporation

CTEV
24
Medical - Healthcare Information Services · Healthcare
Price
$37.27
+3.19 (+9.36%)
Market Cap
$635.4M
Winston Score
24
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Weak
Valuation
Data not available

Winston Score History

The full picture

Claritev Corporation is a healthcare technology company that helps health insurers and other payers manage medical costs. It provides software and data analytics tools that review medical claims — the bills that doctors and hospitals send to insurance companies — to check for errors, flag overcharges, and help negotiate lower payments. The company serves commercial health plans, government programs like Medicaid, and self-insured employers across the United States.

Claritev earns revenue primarily by charging fees based on the volume of claims it processes and the savings it generates for clients, giving it a transaction-based revenue model. It operates mainly in the U.S. and competes in a fragmented market where switching costs and proprietary data networks provide some stickiness with existing clients. With a low operating margin of around 4% and a very low return on invested capital, the key risk is that heavy debt loads from prior acquisitions could limit the company's ability to invest in growth or weather a downturn in healthcare spending.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+8.4% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

57.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$14M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Claritev Corporation is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.9% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 16.3M (2021) → 16.4M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
9.1%
Thin — 9.1% gross margin
Profit after running costs
Operating Margin
9.1%
Modest — 9.1% operating margin
Return on the money invested
ROCE
0.5%
Weak — 0.5% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.3%
Slow sales growth (+6.3% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-1.8%
Burning cash (-1.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
0.12x
Dangerous — barely covers interest (0.1x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial